| __timestamp | Ascendis Pharma A/S | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 13983000 | 55402000 |
| Thursday, January 1, 2015 | 8118000 | 66107000 |
| Friday, January 1, 2016 | 4606000 | 103402000 |
| Sunday, January 1, 2017 | 1530000 | 135736000 |
| Monday, January 1, 2018 | 10581000 | 245116000 |
| Tuesday, January 1, 2019 | 13375000 | 108935000 |
| Wednesday, January 1, 2020 | 6953000 | 156000000 |
| Friday, January 1, 2021 | 4255000 | 214957000 |
| Saturday, January 1, 2022 | 39037000 | 143418000 |
| Sunday, January 1, 2023 | 222323000 | 96265000 |
| Monday, January 1, 2024 | 319383000 |
Unleashing the power of data
In the dynamic world of biotechnology, financial performance can be as volatile as the science itself. Ascendis Pharma A/S and Ligand Pharmaceuticals Incorporated, two prominent players, have shown contrasting trajectories in their gross profit over the past decade.
From 2014 to 2023, Ascendis Pharma A/S experienced a staggering growth in gross profit, culminating in a remarkable 1,500% increase by 2023. This surge highlights the company's strategic advancements and successful product launches. In contrast, Ligand Pharmaceuticals, while maintaining a steady performance, saw its gross profit peak in 2018, with a subsequent decline of about 40% by 2023.
These trends underscore the importance of innovation and market adaptation in the biotech sector. As investors and stakeholders analyze these insights, the data serves as a testament to the ever-evolving landscape of pharmaceutical profitability.
Gross Profit Analysis: Comparing Eli Lilly and Company and Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Merck & Co., Inc. and Ascendis Pharma A/S Trends
Bristol-Myers Squibb Company vs Ascendis Pharma A/S: A Gross Profit Performance Breakdown
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Ligand Pharmaceuticals Incorporated Trends
Gross Profit Comparison: Genmab A/S and Ligand Pharmaceuticals Incorporated Trends
Gross Profit Analysis: Comparing Incyte Corporation and Ascendis Pharma A/S
Gross Profit Trends Compared: Viatris Inc. vs Ligand Pharmaceuticals Incorporated
Dr. Reddy's Laboratories Limited and Ascendis Pharma A/S: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bio-Techne Corporation vs Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Ascendis Pharma A/S and Amneal Pharmaceuticals, Inc. Trends
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and Ligand Pharmaceuticals Incorporated
Key Insights on Gross Profit: Ascendis Pharma A/S vs Travere Therapeutics, Inc.